Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New asthma drug shows promise in Real-World taiwan study

NCT ID NCT05734339

First seen Apr 25, 2026 · Last updated May 17, 2026 · Updated 4 times

Summary

This study tested how well benralizumab, an asthma medication, works for people with severe uncontrolled asthma in everyday settings in Taiwan. 43 adults took the drug and reported their symptoms using questionnaires. The goal was to see if asthma control improved after starting treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Research Site

    Changhua, Taiwan

  • Research Site

    Kaohsiung City, Taiwan

  • Research Site

    New Taipei City, Taiwan

  • Research Site

    Tainan, Taiwan

  • Research Site

    Taipei, Taiwan

  • Research Site

    Taoyuan City, Taiwan

Conditions

Explore the condition pages connected to this study.